Cargando…

Resolution of primary hepatic marginal zone lymphoma in a hepatitis C virus-infected patient treated with a direct-acting antiviral

The favorable impact of antiviral therapy on low-grade hepatitis C virus (HCV)-related non-Hodgkin lymphoma manifesting as marginal zone lymphoma (MZL) has been reported in some clinical studies. However, primary HCV-related marginal zone lymphomas (MZLs) confined to the liver have not been describe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellicelli, Adriano, Giannelli, Valerio, Zoli, Valerio, Regine, Giovanni, Cortese, Andrea, Ettorre, Giuseppe M, Carmenini, Enrico, Pellicelli, Valeria, Rigacci, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143661/ https://www.ncbi.nlm.nih.gov/pubmed/34055359 http://dx.doi.org/10.1093/omcr/omab022

Ejemplares similares

Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma
por: Pellicelli, Adriano, et al.
Publicado: (2018)

Ocular adnexal lymphoma and infectious agents
por: Pellicelli, Adriano M, et al.
Publicado: (2009)

P1096: TREATMENT OF HEPATITIS C-ASSOCIATED MARGINAL ZONE LYMPHOMA(HCV+LMZ) WITH DIRECT-ACTING ANTIVIRAL DRUGS (DAAS)
por: Lepkov, Sergey, et al.
Publicado: (2023)

Hepatitis B in patients with hematological diseases: An update
por: Coluccio, Chiara, et al.
Publicado: (2017)

Hepatic Infiltration by Splenic Marginal Zone Lymphoma in a Patient With Cured Hepatitis C
por: Silva, Leonor, et al.
Publicado: (2021)

Primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
por: Choi, Soyeon, et al.
Publicado: (2020)

Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents
por: Hussein, Maged H., et al.
Publicado: (2018)

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia
por: Yousafzai, Mohammad T., et al.
Publicado: (2022)

Dural Marginal Zone Lymphoma in a Patient With a Hepatitis C Virus Infection
por: Villaume, Matthew T., et al.
Publicado: (2020)

Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
por: Zaimi, Yosra, et al.
Publicado: (2021)

Eustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature
por: Pellicelli, Adriano M, et al.
Publicado: (2005)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
por: Karayiannis, Peter
Publicado: (2012)

Direct-acting antiviral retreatment patterns for hepatitis C
por: Hasan, Shaquib Al, et al.
Publicado: (2022)

High prevalence of viral hepatitis in a series of splenic marginal zone lymphomas from Romania
por: Fetica, B, et al.
Publicado: (2016)

Safety and efficacy of directly‐acting antiviral therapy for chronic hepatitis C virus in elderly people
por: De Santis, Adriano, et al.
Publicado: (2021)

Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods
por: Loggi, Elisabetta, et al.
Publicado: (2017)

Psychiatric treatment considerations with direct acting antivirals in hepatitis C
por: Sockalingam, Sanjeev, et al.
Publicado: (2013)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
por: Ahmed, Asma, et al.
Publicado: (2015)

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
por: Soriano, Vicente, et al.
Publicado: (2022)

Assessing the Risk Factors for Refractory Eosinophilic Esophagitis in Children and Adults
por: Ridolo, Erminia, et al.
Publicado: (2019)

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
por: Ridolo, Erminia, et al.
Publicado: (2019)

Romantic attachment, infertility-related stress, and positive body image of women dealing with infertility
por: Calvo, Vincenzo, et al.
Publicado: (2023)

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2022)

An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
por: Hayashi, Michihiro, et al.
Publicado: (2011)

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
por: Pellicelli, Adriano, et al.
Publicado: (2020)

The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center
por: Montalbano, Marzia, et al.
Publicado: (2020)

Radiotherapy in marginal zone lymphoma
por: Deinbeck, Kristin, et al.
Publicado: (2013)

Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma
por: Xiong, W, et al.
Publicado: (2017)

Direct-acting antivirals for acute hepatitis C in HIV-infected MSM
por: Millard, James Daniel, et al.
Publicado: (2016)

Management of hepatitis C genotype 4 in the directly acting antivirals era
por: Hathorn, Emma, et al.
Publicado: (2016)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
por: Hill, Andrew, et al.
Publicado: (2018)

Hepatitis C virus infection in children in the era of direct-acting antiviral
por: Pawlowska, Malgorzata, et al.
Publicado: (2018)

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
por: Stevenson, Heather L., et al.
Publicado: (2016)

The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C
por: Yang, Christine Hong Ting, et al.
Publicado: (2017)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ttvfos3rik5e8ortqdu4ghhpb